Denali Therapeutics Inc
DNLI
NASDAQ
Biotechnology
$24.40
USD
-0.42 (-1.69%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.05B
Volume 876.2K
Price Target
$29.00 – $35.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $35.00 and a min estimate of $29.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$32.00
-$4.8 vs prior
Implied Upside
+31.1%
-19.5% vs prior
Analyst Covering
2
-6 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
20%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Jessica Fye | JP Morgan | Buy | Resumed | 4 weeks ago | Plus | Plus | Plus |
Matthew Harrison | Morgan Stanley | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
